Please login to the form below

Not currently logged in
Email:
Password:

Just::

This page shows the latest Just:: news and features for those working in and with pharma, biotech and healthcare.

Takeda’s HyQvia receives EC approval for rare neuromuscular disorder CIDP

Takeda’s HyQvia receives EC approval for rare neuromuscular disorder CIDP

The approval comes just under two weeks after HyQvia was approved by the US Food and Drug Administration as a maintenance therapy to prevent the relapse of neuromuscular disability and impairment

Latest news

More from news
Approximately 7 fully matching, plus 3,728 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 3 fully matching, plus 850 partially matching documents found.

Latest appointments

More from appointments
Approximately 3 fully matching, plus 77 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 780 partially matching documents found.

Subscribe to our email news alerts

PMHub

Add my company
IGNIFI

We’re IGNIFI. An independent creative agency, we help spark and sustain successful brands for some of the biggest names in...

Latest intelligence

The evolving healthcare advertising landscape
Industry experts share their insights on the emerging trends in healthcare advertising...
Clinical trial considerations: Why supporting HCPs matters...
When HCPs have the necessary information, they can more easily communicate it to patients using simplified language and a confident, calm tone....
Six ways to provide successful e-learning programs to healthcare professionals
Practical tips to setting up high-impact e-learning programs...